These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
387 related articles for article (PubMed ID: 34562603)
1. Management of inflammation in cardiovascular diseases. Goswami SK; Ranjan P; Dutta RK; Verma SK Pharmacol Res; 2021 Nov; 173():105912. PubMed ID: 34562603 [TBL] [Abstract][Full Text] [Related]
2. Interleukin-1 and the Inflammasome as Therapeutic Targets in Cardiovascular Disease. Abbate A; Toldo S; Marchetti C; Kron J; Van Tassell BW; Dinarello CA Circ Res; 2020 Apr; 126(9):1260-1280. PubMed ID: 32324502 [TBL] [Abstract][Full Text] [Related]
3. Cytokines as therapeutic targets for cardio- and cerebrovascular diseases. Liberale L; Ministrini S; Carbone F; Camici GG; Montecucco F Basic Res Cardiol; 2021 Mar; 116(1):23. PubMed ID: 33770265 [TBL] [Abstract][Full Text] [Related]
4. Anti-inflammatory agents to treat or prevent type 2 diabetes, metabolic syndrome and cardiovascular disease. Esser N; Paquot N; Scheen AJ Expert Opin Investig Drugs; 2015 Mar; 24(3):283-307. PubMed ID: 25345753 [TBL] [Abstract][Full Text] [Related]
5. The Role of Chronic Inflammation in Various Diseases and Anti-inflammatory Therapies Containing Natural Products. Wang RX; Zhou M; Ma HL; Qiao YB; Li QS ChemMedChem; 2021 May; 16(10):1576-1592. PubMed ID: 33528076 [TBL] [Abstract][Full Text] [Related]
6. The Complex Interplay between Lipids, Immune System and Interleukins in Cardio-Metabolic Diseases. Bernardi S; Marcuzzi A; Piscianz E; Tommasini A; Fabris B Int J Mol Sci; 2018 Dec; 19(12):. PubMed ID: 30558209 [TBL] [Abstract][Full Text] [Related]
7. P2X7 Receptors: An Untapped Target for the Management of Cardiovascular Disease. Shokoples BG; Paradis P; Schiffrin EL Arterioscler Thromb Vasc Biol; 2021 Jan; 41(1):186-199. PubMed ID: 32998520 [TBL] [Abstract][Full Text] [Related]
8. Targeting cytokines and immune checkpoints in atherosclerosis with monoclonal antibodies. Lutgens E; Joffre J; van Os B; Ait-Oufella H Atherosclerosis; 2021 Oct; 335():98-109. PubMed ID: 34593238 [TBL] [Abstract][Full Text] [Related]
18. Developmental endothelial locus-1 in cardiovascular and metabolic diseases: A promising biomarker and therapeutic target. Zhao M; Zheng Z; Li C; Wan J; Wang M Front Immunol; 2022; 13():1053175. PubMed ID: 36518760 [TBL] [Abstract][Full Text] [Related]
19. Resolvins as proresolving inflammatory mediators in cardiovascular disease. Capó X; Martorell M; Busquets-Cortés C; Tejada S; Tur JA; Pons A; Sureda A Eur J Med Chem; 2018 Jun; 153():123-130. PubMed ID: 28732558 [TBL] [Abstract][Full Text] [Related]
20. Inflammation and cardiovascular disease: from pathogenesis to therapeutic target. Golia E; Limongelli G; Natale F; Fimiani F; Maddaloni V; Pariggiano I; Bianchi R; Crisci M; D'Acierno L; Giordano R; Di Palma G; Conte M; Golino P; Russo MG; Calabrò R; Calabrò P Curr Atheroscler Rep; 2014 Sep; 16(9):435. PubMed ID: 25037581 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]